Literature DB >> 3488549

BSC-1 growth inhibitor/type beta transforming growth factor is a strong inhibitor of thymocyte proliferation.

H J Ristow.   

Abstract

Growth inhibitor/type beta transforming growth factor purified from BSC-1 cells and human platelets is shown to strongly inhibit the proliferation of Con A-stimulated mouse thymocytes. The inhibition can be achieved with growth inhibitor/type beta transforming growth factor concentrations approximately equal to 1/10th those necessary to inhibit keratinocyte cultures. The inhibitory effect in thymocyte cultures can be reversed by the addition of interleukin 2. These findings suggest that growth inhibitor/type beta transforming growth factor is a naturally occurring immunoregulator.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3488549      PMCID： PMC386321          DOI： 10.1073/pnas.83.15.5531

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  13 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

Authors:  R F Tucker; G D Shipley; H L Moses; R W Holley
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

4.  Purification and properties of a type beta transforming growth factor from bovine kidney.

Authors:  A B Roberts; M A Anzano; C A Meyers; J Wideman; R Blacher; Y C Pan; S Stein; S R Lehrman; J M Smith; L C Lamb
Journal:  Biochemistry       Date:  1983-12-06       Impact factor: 3.162

5.  Purification and initial characterization of a type beta transforming growth factor from human placenta.

Authors:  C A Frolik; L L Dart; C A Meyers; D M Smith; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

6.  Purification of kidney epithelial cell growth inhibitors.

Authors:  R W Holley; P Böhlen; R Fava; J H Baldwin; G Kleeman; R Armour
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

7.  Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.

Authors:  R Derynck; J A Jarrett; E Y Chen; D H Eaton; J R Bell; R K Assoian; A B Roberts; M B Sporn; D V Goeddel
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

8.  Stimulation of DNA synthesis in cultured mouse epidermal cells by human peripheral leukocytes.

Authors:  H J Ristow
Journal:  J Invest Dermatol       Date:  1982-12       Impact factor: 8.551

9.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Authors:  R K Assoian; A Komoriya; C A Meyers; D M Miller; M B Sporn
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  The specific binding of Listeria monocytogenes-immune T lymphocytes to macrophages. I. Quantitation and role of H-2 gene products.

Authors:  K Ziegler; E R Unanue
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307
View more
  34 in total

Review 1.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

2.  Immunohistological analysis of tumour growth factor beta 1 expression in normal and inflamed salivary glands.

Authors:  Y Kizu; H Sakurai; S Katagiri; N Shinozaki; M Ono; K Tsubota; J Saito
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

3.  Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching.

Authors:  D A Lebman; D Y Nomura; R L Coffman; F D Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line.

Authors:  E Helseth; A Dalen; G Unsgaard; R Vik
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

5.  Insulin-like synergistic stimulation of DNA synthesis in Swiss 3T3 cells by the BSC-1 cell-derived growth inhibitor related to transforming growth factor type beta.

Authors:  K D Brown; R W Holley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  Inhibition of Nb2 T-lymphoma cell growth by transforming growth factor-beta.

Authors:  E J Rayhel; D A Prentice; P S Tabor; W H Flurkey; R W Geib; R F Laherty; S B Schnitzer; R Chen; J P Hughes
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

7.  TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis.

Authors:  Monika L Gloviczki; Mira T Keddis; Vesna D Garovic; Hanna Friedman; Sandra Herrmann; Michael A McKusick; Sanjay Misra; Joseph P Grande; Lilach O Lerman; Stephen C Textor
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

8.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

Authors:  T Yamamoto; T Nakamura; N A Noble; E Ruoslahti; W A Border
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Regulation of platelet-derived growth factor gene expression by transforming growth factor beta and phorbol ester in human leukemia cell lines.

Authors:  T P Mäkelä; R Alitalo; Y Paulsson; B Westermark; C H Heldin; K Alitalo
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

10.  Production of TGF-beta1 as a Mechanism for Defective Antigen-presenting Cell Function of Macrophages Generated in vitro with M-CSF.

Authors:  Jae Kwon Lee; Young-Ran Lee; Young-Hee Lee; Kyungjae Kim; Chong-Kil Lee
Journal:  Immune Netw       Date:  2009-02-28       Impact factor: 6.303
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.